XML 27 R8.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statement of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
OPERATING ACTIVITIES    
Net income $ 12,431,000 $ 9,455,000
Adjustments to reconcile net income to net cash provided by operating activities:    
Provision for loan losses 840,000 1,045,000
Investment securities gains on sale, net [1] (886,000)
Loss on equity securities [1] 9,000
Depreciation and amortization of premises and equipment, net 951,000 1,291,000
Software amortization expense 605,000 414,000
Amortization of premium and discount on investment securities, net 419,000 451,000
Accretion of deferred loan fees, net (868,000) (451,000)
Amortization of core deposit intangibles 352,000 374,000
Stock-based compensation expense 467,000 33,000
Origination of loans held for sale (13,196,000) (10,020,000)
Proceeds from sale of loans 13,293,000 10,482,000
Gain on sale of loans (231,000) (291,000)
Origination of student loans held for sale (365,674,000)
Proceeds from sale of student loans 372,162,000
Gain on sale of student loans (535,000)
Earnings on bank-owned life insurance [1] (428,000) (431,000)
Deferred income taxes (241,000) 293,000
Net (gain) loss on other real estate owned (55,000) 30,000
Increase in accrued interest receivable (345,000) (422,000)
Increase in accrued interest payable 166,000 136,000
Other, net 112,000 (3,536,000)
Net cash provided by operating activities 14,281,000 13,920,000
INVESTING ACTIVITIES    
Proceeds from repayments and maturities 7,280,000 14,899,000
Proceeds from sale of securities 0 6,474,000
Purchases (12,999,000) (3,080,000)
Increase in loans, net (68,796,000) (119,866,000)
Proceeds from the sale of other real estate owned 163,000 2,196,000
Purchase of premises and equipment (2,101,000) (1,201,000)
Purchase of restricted stock (90,000) (899,000)
Redemption of restricted stock 795,000
Acquisition, net of cash paid 5,431,000
Net cash used in investing activities (76,543,000) (95,251,000)
FINANCING ACTIVITIES    
Net increase in deposits 137,873,000 50,216,000
Increase in short-term borrowings, net 15,691,000 6,348,000
Repayment of other borrowings (20,262,000) (10,372,000)
Proceeds from other borrowings 30,000,000
Proceeds from common stock issued 15,164,000
Stock options exercised 168,000 184,000
Proceeds from dividend reinvestment and purchase plan 618,000 540,000
Cash dividends (3,779,000) (3,358,000)
Net cash provided by financing activities 130,309,000 88,722,000
Increase in cash and cash equivalents 68,047,000 7,391,000
CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR 39,886,000 32,495,000
CASH AND CASH EQUIVALENTS AT END OF YEAR 107,933,000 39,886,000
Cash paid during the year for:    
Interest on deposits and borrowings 9,743,000 6,511,000
Income taxes 2,125,000 5,705,000
Noncash investing transactions:    
Transfers from loans to other real estate owned 166,000 1,179,000
Common stock issued in business acquisition 20,995,000
Transfer of equity securities from investment securities available for sale, at fair value (625,000)
Noncash assets acquired    
Loans   195,388,000
Loans held for sale   5,953,000
Premises and equipment, net   325,000
Accrued interest receivable   440,000
Bank-owned life insurance   1,681,000
Core deposit intangible   3,087,000
Other assets   997,000
Goodwill   10,740,000
Total noncash assets acquired   218,611,000
Liabilities assumed    
Time deposits   (30,744,000)
Deposits other than time deposits   (167,300,000)
Accrued interest payable   (47,000)
Deferred taxes   (1,134,000)
Other liabilities   (2,754,000)
Total liabilities assumed   (201,979,000)
Liberty stock acquired in business combination   (1,068,000)
Net noncash assets acquired   15,564,000
Cash and cash equivalents acquired, net $ 5,431,000
[1] Not within scope of ASC 606